Andrew Schwartz is a seasoned IT executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the VP/Global Head of IT at ImmunoGen, Inc. since March 2022, Andrew has previously held key leadership positions, including Sr Director and Global IT Leader at Deciphera Pharmaceuticals, and Senior Director of IT at Alkermes. Andrew's experience also includes significant roles at Ipsen, Actavis (now AbbVie), and Pfizer, with a strong focus on IT operations and commercial strategies. Andrew holds a Master's Degree in Computer and Information Sciences from Pace University - Lubin School of Business and a Bachelor of Business Administration from Baruch College, specializing in Business to Business Marketing.